Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Five years ago, we reported that the United States Patent and Trademark Office (USPTO) had awarded CapeRay a key patent to protect our novel dual-modality […]
In 1985, Dr Jay Stein and his good friend David Ellenbogen teamed up to co-found Hologic with 12 employees and the intention […]
It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]
Almost 25 years ago, in 1998, the FDA approved computer-aided detection (CAD) tools as an adjunct to mammography. This was before the […]
The Merriam-Webster dictionary provides three essential meanings for the word “density”: having parts that are close together; being difficult to see through; […]
We are all familiar with the expression, “killing two birds with one stone,” which means to achieve two things by […]
Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]
Earlier this month, we drew attention to the fact that October is traditionally recognised as breast cancer awareness month. It’s therefore appropriate […]
Judging by their marketing, companies are gearing up for widespread adoption of their artificial intelligence (AI) algorithms by breast screening […]